Possible role of NMDA receptors in antinociception induced by rilmenidine in mice in the formalin test

European Journal of Pain

Volumn 11, Issue 5, 2007, Pages 535-541

  Sabetkasaie, Masoomeh ^a   Khansefid, Niaz ^a   Ladgevardi, Mohammad Ali Raies Sadat ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antinociception; Formalin test; Mice; MK 801; Rilmenidine

Indexed keywords

CLONIDINE; DIZOCILPINE; EFAROXAN; FORMALDEHYDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RILMENIDINE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENTIATION; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANALGESICS; ANIMALS; BENZOFURANS; BINDING SITES; BINDING, COMPETITIVE; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EXCITATORY AMINO ACID ANTAGONISTS; IMIDAZOLES; MALE; MICE; NERVOUS SYSTEM; NEURONS, AFFERENT; NOCICEPTORS; OXAZOLES; PAIN; PAIN MEASUREMENT; RECEPTORS, DRUG; RECEPTORS, N-METHYL-D-ASPARTATE; YOHIMBINE;

EID: 34247595547     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2006.07.004     Document Type: Article

References (42)

1. Abbott F.V., Franklin K.B., and Westbrook R.F. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 60 (1995) 91-102
2. Aricioglu F., and Altunbas H. Is agmatine an endogenous anxiolytic/antidepressant agent?. Ann NY Acad Sci 1009 (2003) 136-140
3. Bousquet P., Bruban V., Schann S., and Feldman j. Imidazoline receptors: a challenge. Pharm Acta Helv 74 (2000) 205-209
4. Bousquet P. Imidazoline receptors: from basic concepts to recent developments. J Cardiovasc Pharmacol 26 (1995) S1-S6
5. Bousquet P. Imidazoline receptors. Neurochem Int 30 (1997) 3-7
6. Berrino L., Oliva P., Massimo F., Aurilio C., Maione S., Grella A., et al. Antinociceptive effect in mice of intraperitoneal N-methyl-D-aspartate receptor antagonists in the formalin test. Eur J Pain 7 (2003) 131-137
7. Coderre T.J., and Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12 (1992) 3665-3670
8. Coderre T.J., and Van Empel I. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests. Pain 59 (1994) 345-352
9. Coderre T.J., and Van Empel I. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. II. Assessment of the antinociceptive activity of combinations of competitive and non-competetive NMDA antagonists with agents acting at all allosteric-glycine and polyamine receptor sites. Pain 59 (1994) 353-359
10. Chung K.M., Song D.K., Huh S.O., Kim Y.H., Choi M.R., and Suh H.W. Supraspinal NMDA and non-NMDA receptors are differently involved in the production of antinociception by morphine and β-endorphin administered intracerebroventricularly in the formalin pain model. Neuropeptides 34 (2000) 158-166
11. Dubuisson D., and Dennis S.G. The formalin test: aquantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4 (1977) 161-174
12. Dennis S.G., Melzack R., Gutman S., and Boucher F. Pain modulation by adrenergic agents and morphine as measured by three pain tests. Life Sci 26 (1980) 1247-1259
13. Davidson E.M., and Carlton S.M. Intraplantar injection of dextrophan, ketamine, or memantine attenuates formalin-induced behaviours. Brain Res 785 (1998) 136-142
14. 1-imidazoline receptors. J Cardiovasc Pharmacol 20 (1992) S1-S10
15. Eglan R.M., Hudson A.L., Kendall D.A., Nutt D.J., Morgan N.G., Wilson V.G., et al. Seeing through a glass darkley: Casting light on imidazoline 'I' sites. TiPS 19 (1998) 381-390
16. 2 sites in the mammalian central system. Pharmacol Ther 68 (1995) 175-208
17. 2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice. J Pharmacol Exp Ther 290 (1999) 403-412
18. Fillastre J.P., Lectac B., Galinier F., Le Bihan G., and Schwartz J. A multicenter double-blind study of rilmenidine and clonidine in 333 hypertensive patients. Am J Cardiol (1988) 61D-81D
19. Haley J.E., Sullivan A.F., and Dickenson A.H. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res 518 (1990) 218-226
20. 1-imidazoline receptors in the rostral ventrolateral medulla. J Cardiovasc Pharmacol 24 (1994) S1-S8
21. Kumar A., Ragubir R., and Dhawan B.N. Analgesic effect of morphine, clonidine and serotonin microinjected in the PTN of rats. NeuroReport 4 (1993) 944-946
22. Mihaud D., Fagni L., Bockaert J., and Lafon-cazal M. Imidazoline-induced neuroprotective effects result from blockade of NMDA receptor channels in neuronal cultures. Neuropharmacology 39 (2000) 2244-2254
23. Milligan C.M., and MacKinnon. Imidazoline receptor ligand. DN& P 10 (1997) 74-84
24. Molderings G.J. Imidazoline receptors: basic knowledge, recent advances and future prospects for therapy and diagnosis. Drug Fut 22 (1997) 757-772
25. Omote K., Kawamata T., Kawamata M., and Namili A. Formalin-induced release of excitatory amino acid in the skin of the rat hindpaw. Brain Res 787 (1998) 161-164
26. Omote K., Kawamata T., Kawamata M., Nakayama Y., Hazama K., and Namiki A. Activation of peripheral NMDA-nitric oxide cascade in formalin test. Anesthesiology 93 (2000) 173-178
27. Olmos G., De Gregorio-Rocosolano N., Paz Regalado M., Gassul T., Assumpcio Boronat M., Trullas R., et al. Protection by imidazol (ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol 127 (1999) 1317-1326
28. Olmos G., Ribera J., and Garcia-Sevilla J.A. Imidazoline compounds interact with the phencyclidine site of NMDA receptors in the rat brain. Eur J Pharmacol 310 (1996) 273-276
29. 2-adrenergic agents upon central etorphine antinociception in the cat. Brain Res 309 (1984) 135-142
30. 2-adrenergic receptors. J Pharmacol Exp Ther 272 (1995) 581-587
31. 2-adrenoceptor subtypes. J Pharmacol Exp Ther 279 (1996) 694-702
32. Regunathan S., and Reis D.J. Imidazoline receptors and their endogenous ligands. Annu Rev Pharmacol Toxicol 36 (1996) 511-544
33. Reis D.J. Neurons and receptors in the rostroventrolateral medulla mediating the antihypertensive actions of drugs acting at imidazoline receptors. J Cardiovasc Pharmacol 27 (1996) S11-S18
34. 2 binding sites. Eur J Pharmacol 501 (2004) 95-101
35. 2-adrenergic receptor agonist, moxonidine in comparison with clonidine in the formalin test in rats. Pain 85 (2000) 161-167
36. Taskar R.A.P., and Melzack R. Different α-receptor subtypes are involved in clonidine-produced analgesia in different pain tests. Life Sci 44 (1989) 9-17
37. Tjolsen A., Berge O.G., Hunskaar S., Rosland J.H., and Hole K. The formalin test: an evaluation of the method. Pain 51 (1992) 5-17
38. Van Zwieten P.A., Thoolen M.J., Jonkman F.A., Wilffert B., De Jonge A., and Timmermans P.B. Central and peripheral effects of S 3341 [(N-dicyclopropylmethyl)-amino-2-oxazoline] in animal models. Arch Int Pharmacodyn Ther 279 (1986) 130-149
39. Verbeuren T.J., Dihn Xuan A.T., Koenig-Berard E., and Vitou P. Rilmenidine. Cardiovasc Drug Rev 8 (1990) 56
40. Yamamoto T., and Yaksht L. Comparison of the antinociceptive effects of pre- and post-treatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 77 (1992) 757-763
41. Yang X., and Reis D.J. Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther 288 (1999) 544-549
42. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110